Avanos Medical, Inc. (AVNS)

Market Cap	641.74M
Revenue (ttm)	687.80M
Net Income (ttm)	-392.10M
Shares Out	46.00M
EPS (ttm)	-8.53
PE Ratio	n/a
Forward PE	12.40
Dividend	n/a
Ex-Dividend Date	n/a

Volume	344,370
Open	14.33
Previous Close	14.33
Day's Range	13.87 - 14.33
52-Week Range	13.87 - 25.36
Beta	1.17
Analysts	Hold
Price Target	n/a
Earnings Date	May 1, 2025

About AVNS

Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides non-opioid pain solutions, including surgical pain and recovery products, which comprise ON-Q and ambIT surgical pain pump, Game Ready cold, and compression therapy systems. In addition, ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2014
• Employees: 2,227
• Stock Exchange: NYSE
• Ticker Symbol: AVNS
• Website: https://avanos.com

Financial Performance

In 2024, Avanos Medical's revenue was $687.80 million, an increase of 2.15% compared to the previous year's $673.30 million. Losses were -$392.10 million, 534.5% more than in 2023.